Evaluation of effect of rivaroxaban on resolution of left atrial / left atrial appendage thrombus in patients with non-valvular atrial fibrillation

Evaluation of effect of rivaroxaban on resolution of left atrial / left atrial appendage thrombus in patients with non-valvular atrial fibrillation - Evaluation of effect of rivaroxaban in patients with non-valvular atrial fibrillation

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000016299

Enrollment

Registered

2015-01-21

Start date

2015-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

non-valvular atrial fibrillation

Interventions

rivaroxaban

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients with non-valvular atrial fibrillation and left atrial / left atrial appendage thrombus

Exclusion criteria

Exclusion criteria: patients with cerebrovascular disease

Design outcomes

Primary

Measure	Time frame
resolution of left atrial / left atrial appendage thrombus in patients with non-valvular atrial fibrillation	—

Countries

Japan

Contacts

Public ContactYasuaki Wada

Yamaguchi University Graduate School of Medicine Department of Medicine and Clinical Science

wadayasu@yamaguchi-u.ac.jp0836-22-2248

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026